Nyxoah (NYXH) Depreciation and Depletion (2021 - 2022)

Nyxoah's (NYXH) quarterly Depreciation and Depletion came in at $292811.0 in Q4 2022, down 32.11% year-on-year from $431277.0 in Q4 2021, and down 1.89% quarter-over-quarter from $298449.2 in Q3 2022.

Nyxoah (NYXH) Depreciation and Depletion (2021 - 2022) Analysis & Trends

Nyxoah's Depreciation and Depletion history runs 2 years deep, the most recent figure standing at $292811.0 for Q4 2022.

  • On a quarterly basis, Depreciation and Depletion fell 32.11% year-over-year to $292811.0 in Q4 2022; TTM through Dec 2022 was $1.2 million, a 7.12% increase from a year earlier, with the FY2024 full-year figure at $1.9 million, up 24.47% from the prior year.
  • Depreciation and Depletion fell to $292811.0 in Q4 2022 per NYXH's latest filing, from $298449.2 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $431277.0 in Q4 2021 and bottomed at $197822.7 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Intuitive Surgical 126.02 Bn 120.80 Bn 1.96 Bn -
2 Becton Dickinson 44.98 Bn 44.16 Bn 2.15 Bn -
3 Alcon 33.07 Bn 31.41 Bn 1.53 Bn -
4 Medline 33.03 Bn 30.80 Bn 1.84 Bn -
5 Resmed 29.47 Bn 27.81 Bn 890.98 Mn -
6 West Pharmaceutical Services 23.28 Bn 22.84 Bn 329.20 Mn 45.70 Mn
7 Solventum 14.06 Bn 13.50 Bn 1.10 Bn 38.00 Mn
8 Cooper Companies 13.93 Bn 13.79 Bn 735.40 Mn 47.80 Mn
9 Align Technology 12.10 Bn 11.04 Bn 736.59 Mn 15.60 Mn
10 Nyxoah 52.97 Mn 99.96 Mn 4.26 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 292,810.99
Dec 31, 2022 292,810.99
Sep 30, 2022 298,449.20
Sep 30, 2022 298,449.20
Jun 30, 2022 299,842.93
Jun 30, 2022 299,842.93
Mar 31, 2022 286,196.12
Mar 31, 2022 286,196.12
Dec 31, 2021 431,277.05
Dec 31, 2021 431,277.05
Sep 30, 2021 213,451.01
Sep 30, 2021 213,451.01
Jun 30, 2021 256,509.82
Jun 30, 2021 256,509.82
Mar 31, 2021 197,822.72
Mar 31, 2021 197,822.72